Key opinion leaders (KOLs) are health care leaders who make a high-impact footprint while advancing medical science. Thought Leader Select specializes in delivering objective, validated data on the skills and experiences of KOLs, so that pharmaceutical companies can seek their appropriate advice and guidance in the development of new medicines.
Thought Leader Select measures many areas where KOLs leave their respective marks in the medical community, including conducting clinical research studies, publishing articles in leading journals, and presenting breakthrough knowledge at scientific conferences.
In a recent assessment of 57 infectious disease specialists, Thought Leader Select measured the frequency of these global key opinion leaders’ respective participation in advisory boards for the development of new medicines.
Using keywords to link the KOLs with advisory board participation covering a six-year period, Thought Leader Select found that 37 of the 57 physicians had relevant advisory board experience to assist its client company in the development of new antibiotics. Of the 37 physicians with documented advisory board experience, 20 had served on more than four boards in the last few years.
The top decile for the KOL pool averaged participation in nine or more advisory boards during the period of the study.
